Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

BACKGROUND: BRAF and MEK inhibitors frequently cause cutaneous adverse events. OBJECTIVE: To investigate the cutaneous safety profile of BRAF inhibitors versus BRAF- and MEK-inhibitor combination regimens. METHODS: We performed a retrospective cohort study, collecting data from 44 melanoma patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Acad Dermatol
Main Authors: Sanlorenzo, Martina, Choudhry, Aditi, Vujic, Igor, Posch, Christian, Chong, Kim, Johnston, Katia, Meier, Melissa, Osella-Abate, Simona, Quaglino, Pietro, Daud, Adil, Algazi, Alain, Rappersberger, Klemens, Ortiz-Urda, Susana
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254519/
https://ncbi.nlm.nih.gov/pubmed/25440439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2014.09.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados